Oruka Therapeutics, Stock Annual Yield
| ORKA Stock | 20.26 1.57 8.40% |
Oruka Therapeutics, fundamentals help investors to digest information that contributes to Oruka Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Oruka Stock. The fundamental analysis module provides a way to measure Oruka Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oruka Therapeutics, stock.
Oruka |
Oruka Therapeutics, Company Annual Yield Analysis
Oruka Therapeutics,'s Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Oruka Therapeutics, Annual Yield | 0.78 % |
Most of Oruka Therapeutics,'s fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oruka Therapeutics, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Oruka Therapeutics, has an Annual Yield of 0.7777%. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The annual yield for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Oruka Fundamentals
| Current Valuation | 899.11 M | ||||
| Shares Outstanding | 1000 K | ||||
| Number Of Shares Shorted | 656.34 K | ||||
| Target Price | 41.25 | ||||
| Market Capitalization | 888.26 M | ||||
| Annual Yield | 0.78 % |
About Oruka Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oruka Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oruka Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oruka Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Oruka Therapeutics, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oruka Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oruka Therapeutics, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oruka Therapeutics, Stock:Check out Oruka Therapeutics, Piotroski F Score and Oruka Therapeutics, Altman Z Score analysis. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics,. If investors know Oruka will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oruka Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oruka Therapeutics, is measured differently than its book value, which is the value of Oruka that is recorded on the company's balance sheet. Investors also form their own opinion of Oruka Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Oruka Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oruka Therapeutics,'s market value can be influenced by many factors that don't directly affect Oruka Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oruka Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Oruka Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oruka Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.